Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Evenity Market Size Forecast: How Big Could The Market Get By 2030?
The expansion observed historically stems from an aging female demographic, the widespread occurrence of postmenopausal osteoporosis, shortcomings of antiresorptive medications, a rise in fracture-related illness, and the initial positive results of biologic bone treatments.
The anticipated expansion during the forecast period is linked to increased understanding of bone health, more widespread osteoporosis screenings, the broader application of biologics, improved healthcare accessibility for senior populations, and supportive reimbursement policies for preventing fractures. Key trends throughout this period are expected to include a surge in the use of anabolic osteoporosis therapies, an intensified focus on reducing fracture risk, a growing preference for monthly injectable treatments, short-duration high-efficacy osteoporosis regimens, and the integration of biologic therapies within bone health management.
Get A Free Sample Report With In-Depth Market Insights:
Evenity Market Growth Drivers: What’s Behind The Acceleration?
The Evenity market is anticipated to expand as the occurrence of osteoporosis becomes more widespread. Osteoporosis is a medical condition marked by a reduction in bone density and quality, rendering bones weaker and more susceptible to fractures. This increase in osteoporosis cases is attributed to an aging demographic experiencing a natural decline in bone density, alongside sedentary lifestyles that diminish skeletal strength. Evenity is administered monthly, for a maximum of 12 months, to treat osteoporosis by stimulating bone formation, decreasing bone breakdown, and reinforcing bones to avert fractures. For instance, in February 2023, the Royal Osteoporosis Society, a UK based charity, presented written evidence estimating that fragility fractures incur an annual cost of $5.89billion (£4.5 billion) for the NHS, with hip fractures alone accounting for $2.62 billion (£2 billion) of this total. Consequently, the rising prevalence of osteoporosis is stimulating growth in the Evenity market.
Evenity Market Segment Analysis: What Are The Core Market Categories?
The evenity market covered in this report is segmented –
1) By Indication: Postmenopausal Osteoporosis, Osteoporosis In Men
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Hospitals And Clinics, Specialty Centers, Homecare Settings, Research And Academic Institutions
Evenity Market Top Companies Driving Competitive Growth
Major companies operating in the evenity market are Amgen Inc., UCB S.A
View The Full Evenity Market Report:
Evenity Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the evenity market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evenity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
